Position in XERS
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$4,208,572
+$2,812,670 QoQ
Shares Held
725,616
+308.1% QoQ
Ownership
0.420%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in XERS Over Time
Shares Held
Position Value (USD)
Derivatives in XERS
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$107,300
PutShares
18,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026JANE STREET GROUP, LLC holds $182,242,360 across 41 Drug Manufacturers - Specialty & Generic names. XERS ranks #8 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,464,638 | $44,114,896 | |
| 2 | LQDA |
Liquidia Corp
|
795,884 | $30,036,661 | |
| 3 | VTRS |
Viatris Inc
|
2,192,665 | $29,622,903 | |
| 4 | HLN |
Haleon plc
|
2,291,768 | $22,940,596 | |
| 5 | BCRX |
Biocryst Pharmaceuticals Inc
|
622,607 | $5,927,217 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
240,170 | $4,985,929 | |
| 7 | AQST |
Aquestive Therapeutics, Inc.
|
1,030,050 | $4,274,707 | |
| 8 | XERS |
Xeris Biopharma Holdings, Inc.
This page
|
725,616 | $4,208,572 |
All Filings in XERS
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,208,572 | 725,616 | Shares | Defined | 2026-05-12 | |
| 2026-03-31 | $107,300 | 18,500 | Put | Defined | 2026-05-12 | |
| 2025-12-31 | $102,835 | 13,100 | Call | Defined | 2026-02-12 | |
| 2025-12-31 | $1,395,902 | 177,822 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $306,878 | 37,700 | Call | Defined | 2025-11-14 | |
| 2025-09-30 | $7,437,989 | 913,758 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $85,928 | 18,400 | Call | Defined | 2025-08-14 | |
| 2025-06-30 | $145,539 | 31,165 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $71,919 | 13,100 | Call | Defined | 2025-05-19 | |
| 2025-03-31 | $4,503,017 | 820,222 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $1,038,170 | 306,245 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $908,464 | 318,760 | Shares | Defined | 2024-11-15 | |
| 2024-06-30 | $782,081 | 347,592 | Shares | Defined | 2024-08-15 | |
| 2024-03-31 | $508,206 | 229,958 | Shares | Defined | 2024-05-16 | |
| 2023-12-31 | $525,421 | 223,584 | Shares | Defined | 2024-02-15 | |
| 2023-09-30 | $267,103 | 143,604 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $331,207 | 126,415 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $221,389 | 135,822 | Shares | Defined | 2023-05-16 | |
| 2022-12-31 | $241,476 | 181,562 | Shares | Defined | 2023-02-15 | |
| 2022-09-30 | $183,452 | 117,598 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $410,095 | 266,296 | Shares | Defined | 2022-08-16 | |
| 2022-03-31 | $1,184,970 | 462,879 | Shares | Defined | 2022-05-17 | |
| 2022-03-31 | $222,208 | 86,800 | Call | Defined | 2022-05-17 | |
| 2022-03-31 | $26,368 | 10,300 | Put | Defined | 2022-05-17 | |
| 2021-12-31 | $332,290 | 113,410 | Shares | Defined | 2022-02-15 | |
| 2021-12-31 | $67,683 | 23,100 | Put | Defined | 2022-02-15 | |
| 2021-12-31 | $565,490 | 193,000 | Call | Defined | 2022-02-15 | |
| No filing history on record for this holder in this stock. | ||||||